Literature DB >> 5165300

Glutamic acid decarboxylase in Parkinson's disease and epilepsy.

P L McGeer, E G McGeer, J A Wada.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5165300     DOI: 10.1212/wnl.21.10.1000

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  3 in total

Review 1.  Review: Normal and abnormal central nervous system GABA metabolism in childhood.

Authors:  J Jaeken; P Casaer; K D Haegele; P J Schechter
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  CSF and plasma GABA levels in Parkinson's disease.

Authors:  R J Abbott; I F Pye; S R Nahorski
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

3.  A comparative study of the pharmacology of inhibitors of GABA-metabolism.

Authors:  W Löscher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.